- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Zofran ( Ondansetron )
Zofran (ondansetron) is a selective serotonin 5‑HT3 receptor antagonist indicated for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy and radiotherapy, and for the prevention and treatment of postoperative nausea and vomiting. It works by blocking 5‑HT3 receptors in the chemoreceptor trigger zone and gastrointestinal tract, reducing the emetogenic signal to the vomiting centre. Ondansetron is not a dopamine antagonist and has a low risk of extrapyramidal side effects. It is available as tablets, orally disintegrating tablets, oral solution, and injection.
Usual adult dose: For chemotherapy‑induced nausea and vomiting, the recommended oral dose is 8 mg taken 30 minutes before chemotherapy, followed by 8 mg every 8 to 12 hours for 1 to 2 days after completion of chemotherapy. For highly emetogenic chemotherapy, a 24 mg dose may be used under specialist supervision. For radiation‑induced nausea and vomiting, 8 mg is taken 1 to 2 hours before radiotherapy, then every 8 hours as needed. For postoperative nausea and vomiting, 16 mg may be given 1 hour before anaesthesia. The 4 mg tablet is used for lower intensity regimens or for dose adjustment in hepatic impairment; the maximum daily dose is 8 mg in patients with severe hepatic impairment. The orally disintegrating tablet should be placed on the tongue and allowed to dissolve, then swallowed with saliva; no water is needed.
Dosage form: Film‑coated tablets: 4 mg and 8 mg (white to off‑white, round or oval). Also available as orally disintegrating tablets in 4 mg and 8 mg strengths, oral solution (4 mg/5 mL), and injection (2 mg/mL) for intravenous or intramuscular use.
Onset of action: The antiemetic effect begins within 30 to 60 minutes after oral administration, with peak plasma concentrations at approximately 2 hours. The orally disintegrating tablet has a similar onset profile. For optimal prophylaxis against chemotherapy‑induced nausea, the first dose should be given before the chemotherapeutic agent.
Duration of action: The elimination half‑life of ondansetron is approximately 3 to 6 hours in healthy adults, but the antiemetic effect persists for 8 to 12 hours, supporting dosing every 8 hours as needed.
Alcohol recommendation: Alcohol should be avoided or limited during treatment with Zofran. Alcohol may worsen nausea and dehydration, and may increase the risk of dizziness or drowsiness when combined with ondansetron. Patients should avoid driving or operating machinery if they feel sedated.
Most common side effects: Headache, constipation, dizziness, and fatigue are most frequently reported. Headache is the most common adverse effect, occurring in up to 25% of patients. Ondansetron can cause QT interval prolongation, particularly with high doses or in patients with electrolyte abnormalities, heart failure, or concomitant use of other QT‑prolonging drugs. Serotonin syndrome is a rare but serious reaction, especially when ondansetron is combined with other serotonergic agents such as SSRIs, SNRIs, or tramadol. The 4 mg and 8 mg doses should not be used for prevention of chemotherapy‑induced nausea in patients with severe hepatic impairment; a lower maximum dose is required. Patients should be counselled to report palpitations, dizziness, or severe constipation. Ondansetron does not prevent delayed nausea and vomiting in all patients; additional antiemetics such as dexamethasone or aprepitant may be needed for highly emetogenic chemotherapy. Zofran is available only by prescription in Canada, although some lower strengths may be available behind the counter in certain provinces for specific indications under pharmacist assessment.
Would you like to try Zofran (Ondansetron) without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
